Zentiva Publishes Sustainability Report, Strengthening Commitment to People, Partners and the Planet

Zentiva, a leading pharmaceutical company, has published its 2025 Sustainability Report, showcasing the firm's continued commitment to sustainable development and its impact on people, partners, and the planet. According to the report, Zentiva has made significant strides in several key areas, including: **Public Health Impact**: The company has expanded access to essential medicines, with a focus on underserved communities. Zentiva has also invested in research and development to address unmet medical needs. **Environmental Management**: Zentiva has implemented measures to reduce its carbon footprint, including the use of renewable energy sources and the optimization of its manufacturing processes. The report also highlights the company's efforts to minimize waste and promote the circular economy. **Responsible Practices**: The pharmaceutical firm has strengthened its governance structures and ethical standards, ensuring transparent and accountable operations. Zentiva has also prioritized the well-being of its employees and fostered collaborative partnerships with its stakeholders. 'This report underscores our unwavering commitment to sustainable development and our responsibility to positively impact the lives of people, our partners, and the planet,' said Zentiva's CEO, Jiri Mikula. 'We will continue to build on this progress and drive meaningful change within the industry.' The publication of Zentiva's Sustainability Report aligns with the growing emphasis on environmental, social, and governance (ESG) considerations in the maritime and broader business sectors. As the industry navigates evolving regulatory landscapes and societal expectations, such transparent reporting on sustainability initiatives is becoming increasingly crucial.